Skip to content

TVTX

Travere Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · US

$62.76
−3.06%
Ask drillr
0
Insider buys (3m)
46
Insider sells (3m)
-$67.0M
Net value (3m)
+13.8%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Sep 17, 2026Dube Eric M · director, officer: CHIEF EXECUTIVE OFFICERSale28,796$63
Sep 17, 2026Dube Eric M · director, officer: CHIEF EXECUTIVE OFFICERSale6,802$65
Sep 17, 2026ROTE WILLIAM E. · officer: Chief Research OfficerM-Exempt55,000$15
Sep 17, 2026Dube Eric M · director, officer: CHIEF EXECUTIVE OFFICERSale96,125$64
Sep 17, 2026REED ELIZABETH E · officer: Chief Legal Officer and GCM-Exempt37,500$15
Sep 17, 2026REED ELIZABETH E · officer: Chief Legal Officer and GCSale21,926$62
Sep 17, 2026Calvin Sandra · officer: SVP, CHIEF ACCOUNTING OFFICERSale300$64
Sep 17, 2026Inrig Jula · officer: EVP, Head of R&D & CMOSale25,390$62
Sep 17, 2026Heerma Peter · officer: EVP, CHIEF COMMERCIAL OFFICERSale79,113$64
Sep 17, 2026Heerma Peter · officer: EVP, CHIEF COMMERCIAL OFFICERM-Exempt36,526$8.93
Sep 17, 2026Inrig Jula · officer: EVP, Head of R&D & CMOSale400$65
Sep 17, 2026ROTE WILLIAM E. · officer: Chief Research OfficerSale65,104$63
Sep 17, 2026Dube Eric M · director, officer: CHIEF EXECUTIVE OFFICERSale63,498$62
Sep 17, 2026Heerma Peter · officer: EVP, CHIEF COMMERCIAL OFFICERSale71,938$62
Sep 17, 2026Inrig Jula · officer: EVP, Head of R&D & CMOM-Exempt32,395$8.93
Sep 17, 2026Dube Eric M · director, officer: CHIEF EXECUTIVE OFFICERSale270$65
Sep 17, 2026Heerma Peter · officer: EVP, CHIEF COMMERCIAL OFFICERSale8,282$65
Sep 17, 2026Inrig Jula · officer: EVP, Head of R&D & CMOSale1,600$64
Sep 17, 2026ROTE WILLIAM E. · officer: Chief Research OfficerM-Exempt350$18
Sep 17, 2026REED ELIZABETH E · officer: Chief Legal Officer and GCSale1,400$64
Sep 17, 2026Heerma Peter · officer: EVP, CHIEF COMMERCIAL OFFICERM-Exempt55,000$15
Sep 17, 2026Calvin Sandra · officer: SVP, CHIEF ACCOUNTING OFFICERSale800$63
Sep 17, 2026Calvin Sandra · officer: SVP, CHIEF ACCOUNTING OFFICERM-Exempt1,250$22
Sep 17, 2026Heerma Peter · officer: EVP, CHIEF COMMERCIAL OFFICERM-Exempt17,717$27
Sep 17, 2026Cline Christopher R. · officer: CHIEF FINANCIAL OFFICERSale1,900$64
Sep 17, 2026Cline Christopher R. · officer: CHIEF FINANCIAL OFFICERM-Exempt20,000$17
Sep 17, 2026ROTE WILLIAM E. · officer: Chief Research OfficerSale47,746$64
Sep 17, 2026Cline Christopher R. · officer: CHIEF FINANCIAL OFFICERSale27,473$62
Sep 17, 2026Dube Eric M · director, officer: CHIEF EXECUTIVE OFFICERM-Exempt95,666$23
Sep 17, 2026Heerma Peter · officer: EVP, CHIEF COMMERCIAL OFFICERSale27,421$63
Institutional positioning

13F filings over the trailing two quarters

New 137Increased 215Reduced 183Sold out 29
FilerActionSharesFiled
JANUS HENDERSON GROUP PLCIncreased11,419,586May 18, 2026
Jupiter Topco LLCNew Position11,324,191Aug 14, 2026
FMR LLCIncreased10,967,967May 15, 2026
BlackRock, Inc.Increased8,020,663Aug 7, 2026
BLACKROCK, INC.Reduced7,792,033May 13, 2026
FMR LLCReduced7,096,614Aug 13, 2026
STATE STREET CORPIncreased4,959,988May 15, 2026
ARMISTICE CAPITAL, LLCIncreased4,897,417May 15, 2026
BANK OF AMERICA CORP /DE/Increased4,568,341Aug 14, 2026
STATE STREET CORPReduced4,256,224Aug 7, 2026
PERCEPTIVE ADVISORS LLCReduced4,142,551May 29, 2026
VANGUARD CAPITAL MANAGEMENT LLCIncreased4,108,694Aug 13, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position4,045,812May 15, 2026
PERCEPTIVE ADVISORS LLCReduced3,752,574Aug 14, 2026
MACQUARIE MANAGEMENT HOLDINGS, INC.Reduced3,270,513May 15, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 17, 2026